BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21681603)

  • 1. Lack of prognostic significance of survivin in pediatric medulloblastoma.
    Faccion RS; Ferreira RM; Grabois MF; Fonseca TC; de Oliveira JA; Maia RC
    Pathol Oncol Res; 2011 Dec; 17(4):899-908. PubMed ID: 21681603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin expression in medulloblastoma: a possible marker for survival.
    Abdel-Aziz A; Mohamed MA; Akl FM; Taha AN
    Pathol Oncol Res; 2013 Jul; 19(3):413-9. PubMed ID: 23242569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin is a negative prognostic marker in medulloblastoma.
    Pizem J; Cört A; Zadravec-Zaletel L; Popovic M
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):422-8. PubMed ID: 16008826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome.
    Fangusaro JR; Jiang Y; Holloway MP; Caldas H; Singh V; Boué DR; Hayes J; Altura RA
    Br J Cancer; 2005 Jan; 92(2):359-65. PubMed ID: 15655550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker.
    Saito T; Arifin MT; Hama S; Kajiwara Y; Sugiyama K; Yamasaki F; Hidaka T; Arita K; Kurisu K
    J Neurooncol; 2007 Apr; 82(2):193-8. PubMed ID: 17151933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of survivin splice isoforms in medulloblastomas.
    Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC
    Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.
    Augello C; Caruso L; Maggioni M; Donadon M; Montorsi M; Santambrogio R; Torzilli G; Vaira V; Pellegrini C; Roncalli M; Coggi G; Bosari S
    BMC Cancer; 2009 Apr; 9():125. PubMed ID: 19397802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nuclear and cytoplasmic expressions of survivin in glioma and their prognostic value].
    Pan Y; Hu WH; Xie D; Wu QL; Liu YH; Xiang J; Wu HX
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):325-9. PubMed ID: 17456361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subcellular localization of survivin in non-small cell lung cancer].
    He L; Hou M; Zhang J; Xu N; Chen P
    Ai Zheng; 2009 Sep; 28(9):955-60. PubMed ID: 19728914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma.
    Zhao X; Song T; He Z; Tang L; Zhu Y
    Med Oncol; 2010 Sep; 27(3):985-91. PubMed ID: 19806481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma.
    Park AK; Lee JY; Cheong H; Ramaswamy V; Park SH; Kool M; Phi JH; Choi SA; Cavalli F; Taylor MD; Kim SK
    BMC Cancer; 2019 Jun; 19(1):571. PubMed ID: 31185958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.
    Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC
    J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressed TP73 induces apoptosis in medulloblastoma.
    Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
    BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients.
    Priller M; Pöschl J; Abrão L; von Bueren AO; Cho YJ; Rutkowski S; Kretzschmar HA; Schüller U
    Clin Cancer Res; 2011 Nov; 17(21):6791-801. PubMed ID: 21918172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.
    Haberler C; Slavc I; Czech T; Gelpi E; Heinzl H; Budka H; Urban C; Scarpatetti M; Ebetsberger-Dachs G; Schindler C; Jones N; Klein-Franke A; Maier H; Jauk B; Kiefer A; Hainfellner JA
    Eur J Cancer; 2006 Nov; 42(17):2996-3003. PubMed ID: 16996732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia.
    Troeger A; Siepermann M; Escherich G; Meisel R; Willers R; Gudowius S; Moritz T; Laws HJ; Hanenberg H; Goebel U; Janka-Schaub GE; Mahotka C; Dilloo D
    Haematologica; 2007 Aug; 92(8):1043-50. PubMed ID: 17640858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma.
    Andrade AF; Borges KS; Suazo VK; Geron L; Corrêa CA; Castro-Gamero AM; de Vasconcelos EJ; de Oliveira RS; Neder L; Yunes JA; Dos Santos Aguiar S; Scrideli CA; Tone LG
    Invest New Drugs; 2017 Feb; 35(1):26-36. PubMed ID: 27785591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.
    Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Masumori N; Sato N; Tsukamoto T
    Virchows Arch; 2013 Jan; 462(1):101-7. PubMed ID: 23179762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survivin expression in childhood medulloblastomas: a possible diagnostic and prognostic marker.
    Bodey B; Bodey V; Siegel SE; Kaiser HE
    In Vivo; 2004; 18(6):713-8. PubMed ID: 15646811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
    Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
    J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.